Overview

One aspect of the comprehensive 2019 revision of the Act on Pharmaceuticals and Medical Devices ("PMD Act") is to step up enforcement regarding pharma advertising. Since 1 August 2021, an administrative penalty is charged amounting to 4.5 % of the profits made from (quasi-)pharmaceuticals or medical devices that were marketed using false or misleading advertising.

This new regime will significantly increase the risk of sanctions compared to similar rules under German law, which makes it vital for pharmaceutical companies active in the Japanese market to be aware of the diverging risk profile.

About the Event

Mr. Habe, quality assurance manager at B. Braun Aesculap Japan Co., Ltd. will share challenges and measures taken in response to the PMD Act from a business perspective.

Following Mr. Habe’s practical insights, the keynote speech by Japanese attorney Mr. Shingo Noguchi, specialized in healthcare and regulatory issues at TMI Associates, and Dr. Carmen Appenzeller, German attorney at ARQIS Foreign Law Office, will outline the new legal requirements and give plenty of real-life examples of the "dos and don’ts" in pharma advertising.

-----------------------------------------
Disclaimer ©2022 German Chamber of Commerce and Industry in Japan (AHK Japan). No part of this presentation may be reproduced without prior permission. While every reasonable effort is made to ensure that the information provided is accurate, no guarantees for the currency or accuracy of information are made. All material relating to information, products and services (or to third party information, products and services), is provided 'as is', without any representation or endorsement made and without warranty of any kind, including the implied warranties of satisfactory quality, fitness for a particular purpose, non-infringement, compatibility, security and accuracy. The speakers are solely responsible for the content thereof; In no event will the organizer and/or the speakers be liable for any loss or damage whatsoever arising from infringement or any defect of rights of the content of the presentation. Views expressed are not necessarily those of AHK Japan. All our events follow Chatham House Rules. We are working with [Zoom] to bring this online presentation to you. When joining the event, you will be bound by Zoom's terms of service, including it's privacy policy which you can download from the [Zoom] website or access through the mobile application. Please note that we have no responsibility for the collection or use of your personal data by [Zoom] or any third party application.